An Alabama-based doctor pleaded guilty on Oct. 1, 2025, in federal court in Boston to a $6 million telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME) and genetic testing primarily used to detect mutations in genes that could indicate a higher risk of developing certain types of cancers. Tommie Robinson, 43, pleaded guilty to one count of healthcare fraud. Between December 2018 and March 2021, Robinson worked with telemedicine companies to sign medical documentation, including doctors’ orders, for medically unnecessary durable medical equipment and genetic testing. The orders Robinson signed were pre-populated based on telemarketing calls made to Medicare beneficiaries. Robinson generally did not contact the beneficiaries himself and had no medical relationship with the beneficiaries. DME suppliers and laboratories ultimately submitted claims to Medicare for these signed orders. As a result of Robinson’s participation in this scheme, over $6 million in claims were submitted to Medicare for DME and genetic testing that were medically unnecessary, based on false documentation and tainted by kickbacks.